EcoDrugPlus

Ensembl ID : ENSNFUG00015013156
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Ensembl ID : ENSNFUG00015018003
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSNFUG00015018402
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSNFUG00015009302
Gene Symbol: -
Cross references: -
380 Possible Orthologues:

Ensembl ID : ENSNFUG00015010200
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSNFUG00015018406
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSNFUG00015013085
Gene Symbol: -
Cross references: -
242 Possible Orthologues:

Ensembl ID : ENSNFUG00015021304
Gene Symbol: RPL24
1 Cross references
318 Possible Orthologues:

Ensembl ID : ENSNFUG00015014507
Gene Symbol: -
Cross references: -
240 Possible Orthologues:

Ensembl ID : ENSNFUG00015025186
Gene Symbol: -
1 Cross references
205 Possible Orthologues:

Ensembl ID : ENSNFUG00015012549
Gene Symbol: RPL18A
1 Cross references
364 Possible Orthologues:

Ensembl ID : ENSNFUG00015021328
Gene Symbol: -
1 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).